Transport across the cell membrane is crucial in drug delivery. However, the process is complicated because nucleoside derivatives that are commonly used as anti-viral drugs are transported through two different types of specific transporter: concentrative transporters and equilibrative transporters. Cross-disciplinary approaches involving both biological experiments and theoretical considerations are therefore necessary to study the transport of nucleoside analogues such as ribavirin. Here we constructed an experimental model system using the Xenopus laevis oocyte that expressed examples of both types of transporter: human concentrative nucleoside transporter 3 and human equilibrative transporter 1. We also performed a kinetic study. Experimental results showed that the transport of ribavirin could be reduced by inhibiting one of the two types of transporter, which seems to be counterintuitive. We therefore designed a simple mathematical model of the dynamics of ribavirin uptake and analyzed the model behaviors using a numerical simulation. The theoretical results reproduced the experimentally observed phenomena and suggested a possible mechanism for the process. Based on this mechanism, we predicted some potential methods for the effective uptake of ribavirin from a dynamics point of view.
in humans: hCNT1, which is pyrimidine nucleoside-selective; hCNT2, which is purine nucleoside-selective; and hCNT3, which is broadly selective for both pyrimidine and purine nucleosides [7, 8, 9, 10] . Generally, CNTs have a higher affinity for nucleosides than that of equilibrative nucleoside transporters (ENTs) [5] . ENTs are passive transporters, for which the motive force of transport is the difference in nucleoside concentration across a membrane [11, 12] . The uptake of nucleosides is a complex process due to the involvement of these two different types of transporter.
Our comprehension of nucleoside transport across cell membranes has been further complicated by reports of seemingly counterintuitive phenomena [13] . This might be because of the different types of transporter involved [14] , and the complex coupling of the processes of metabolism and signal transduction of nucleosides [15] . To clarify the effects of these factors on nucleoside transport, it could be useful to design and analyze a simplified artificially reconstructed experimental system.
Here, we shed light on the kinetics of combination of both types of transporter.
We constructed an experimental model cell system using the Xenopus laevis oocyte, in which both types of transporter, hCNT and hENT, were coexpressed. It is important to note that the expressed transporters were not rodent but human. Using this model cell system, we performed a kinetic study of ribavirin uptake and tested the effects of the specific inhibition of each type of transporter.
Our results revealed that the uptake of ribavirin was facilitated by the inhibition of an ENT, even though the ribavirin concentration was comparatively high outside of the cell. This phenomenon involved both the complexity of the coupled dynamics of the two transporters and spatial diffusion. We further investigated this effect by constructing and numerically analyzing a simple mathematical model for the dynamics of ribavirin transport.
The insights into the interactive effects of CNTs and ENTs revealed by our simplified model system of the oocyte led us to propose some possible methods for the effective uptake of ribavirin in intrinsic human cell systems. One such method was the organselective delivery of ribavirin depending on differences in the CNT/ENT ratio, which was based on the dynamic characteristics of the behaviors shown by the model. The cross-disciplinary approach involving biological and mathematical sciences proved to be a powerful tool in the current study.
Experimental study of kinetics of ribavirin transport 2.1 Materials and methods

Materials
[3H]-ribavirin was purchased from Moravek Biochemicals (Brea, CA) and ribavirin was purchased from ICN Biomedicals (Aurora, OH). Nitrobenzeylmercaptopurine ribonucleoside (NBMPR), which inhibits ENTs but not CNTs, was purchased from Sigma (St.
Louis, MO). All other compounds were of reagent grade.
Expression of recombinant hCNT3 and hENT1 in Xenopus oocytes
The molecular cloning of hCNT3 and hENT1 was as previously described [16] . hCNT3
and hENT1 complementary RNAs (cRNAs) were synthesized from a linearized plasmid using mMESSAGE mMACHINE and a poly(a) tailing kit (Ambion, Austin, TX On the following day, the oocytes were microinjected with either 50 nL water containing cRNA or 50 nL water alone. The injected oocytes were incubated in modified Barth ?fs solution (which was changed daily) for either 3 days (radioisotope-transport studies) or 3-4 days (electrophysiological studies) at 16 o C.
Radioisotope-transport studies
Uptake experiments were performed at room temperature [16] . The transport buffer used in this study was ND96 solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , and 5 mM HEPES; pH adjusted to 7.4 by Tris). Sodium-free buffer was used in which radioactivity was measured by a liquid scintillation counter. The uptake of ribavirin was calculated by subtracting the rate of uptake by water-injected oocytes from the rate of uptake by cRNA-injected oocytes.
Electrophysiological studies
The electrophysiological studies were performed using the two-microelectrode voltage clamp (TEVC) technique [17, 18] . The microelectrode was prepared from glass capillaries (Hirschmann Laborgerate, Eberstadt, Germany) with the PC-10 Puller (Narishige, Tokyo, Japan), which had a resistance of 1.0-1.5 MΩ and was filled with 3 M KCl. The oocytes were penetrated with the microelectrodes and perfused with the same buffer used for radioisotope-transport studies at 20 o C. The membrane potential of the oocytes was generally held at -50 mV, and the substrate-induced membrane current was measured using the two-electrode voltage clamp amplifier CEZ-1250 (Nihon Kohden Industry, Tokyo, Japan). For the current-voltage relationship study, the membrane potential was changed from +50 mV to -150 mV (in 20 mV decrements) using a personal computer (PC) via the analog-to-digital/digital-to-analog (AD/DA) converter PCI-360216 (Interface, Hiroshima, Japan).
Ribavirin uptake by
Xenopus oocytes coexpressing hCNT3 and hENT1
Effect of Na + and NBMPR on uptake of ribavirin
We examined the effects of transporter inhibition on the uptake rate of ribavirin, as shown in Fig. 1a . The uptake was 0.02 pmol/oocyte/min when both types of transporter were not inhibited ('NaCl' in Fig. 1a ), whereas the inhibition of hENT ('Na + and NBMPR') increased the uptake by four times to 0.08 pmol/oocyte/min. This implied the presence of an underlying interaction between the two types of transporter. By contrast, the inhibition of hCNT ('NMDG Cl') decreased the uptake by half to 0.01 pmol/oocyte/min compared to that with no inhibition. This finding was understandable. When both types of transporter were inhibited ('NMDG + NBMPR'), the uptake was negligible (less than 0.001 pmol/oocyte/min). Figure 1b shows the time courses of uptake under the different conditions. For all of the conditions involving inhibition, the uptake was proportional to the time for the first 5 to 30 min. This linearity of uptake indicates that both types of transporter work effectively in the oocyte.
Concentration-dependent uptake of ribavirin
To characterize the kinetics of the ribavirin uptake under the conditions involving inhibition, we examined the concentration dependency. During the time course of uptake, we found that the uptake of ribavirin increased linearly for at least 30 min (Fig. 1b) .
However, after ribavirin has been transported into the oocyte, it is expected to be metabolized; this might significantly decrease the amount of non-metabolized ribavirin in the oocyte, and affect the transport of ribavirin. Therefore, to avoid any effect of metabolism, we shortened the incubation time as much as possible (to 10 min) and examined the concentration-dependent uptake.
[3H]-ribavirin was added to the buffer with Na + at 0.2 µCi/100 µL/oocyte and to the buffer without Na + at 1 µCi/100 µL/oocyte.
In the buffer with Na + and without NBMPR (no inhibition), the uptake of ribavirin showed a biphasic time course, as indicated by the Eadie-Hofstee plot (Fig. 2c ). This suggested that both types of transporter still worked as the phases observed at low and high concentrations might have been due to hCNT3 and hENT1, respectively.
The uptake of ribavirin in the buffer with Na + and NBMPR ?(hENT inhibition alone), and without Na + and NBMPR ?(hCNT inhibition alone), followed MichaelisMenten-type kinetics. The kinetic parameters were Km=17.7 ± 3.72 µM and Vmax=95.9 ± 3.85 pmol/oocyte/10 min with hENT inhibition (Fig. 2a) , and Km=4.05 ± 0.951 mM and Vmax=892 ± 70.2 pmol/oocyte/10 min with hCNT inhibition (Fig. 2b) . These values were comparable to those that were previously reported in the oocytes expressing hCNT3 alone and hENT1 alone.Each type of transporter worked effectively in the oocytes coexpressing hCNT3 and hENT1. This result shows that hCNT3 and hENT1 did not interact in a direct way like a molecular interaction.
Ribavirin-induced current
We examined the transport activity of hCNT3 by monitoring the sodium current under the inhibitory condition for hENT1. As shown in Fig. 3a , the ribavirin-induced current in oocytes coexpressing hCNT3 and hENT1 showed voltage dependency and was unaffected by adding NBMPR. Furthermore, the concentration dependency of the ribavirin-induced current showed saturability (Fig. 3b) . The Km and I max values were 28.2 ± 3.27 µM and -157.0 ± 7.12 nA for the uptake in the buffer with Na + and without NBMPR ?f (no inhibition), and 36.5 ± 5.03 µM and -161.9 ± 9.50 nA for the uptake in the buffer with Na + and NBMPR ?(hENT1 inhibition). No significant difference was observed in these two conditions. This result confirmed that the transport through hCNT3 was not inhibited by NBMPR and was similar to that without NBMPR.
Effect of hENT1 expression level on uptake of ribavirin
The abovementioned results suggest that ribavirin transport activity of hCNT3 is altered by neither addition of NBMPR nor co-expression of hENT1. We therefore assumed that hENT1 transports ribavirin from inside to outside of the cells. It is opposite direction against hCNT3 does. To examine this hypothesis, we changed the quantity of hENT1 cRNA injected into the oocytes from 0 ng to 50 ng in 12.5 ng increments, while the quantity of hCNT3 cRNA was held constant at 50 ng (the total volume injected into the oocytes was held constant at 50 nL). As shown in Fig. 4 , according to the decrease in the quantity of hENT1 cRNA, the uptake of ribavirin in the buffer with Na + and without NBMPR (no inhibition) increased up to a level similar to that with Na + and NBMPR (hENT1 inhibition). The uptake seen with the hCNT3 inhibition increased as the quantity of hENT1 cDNA increased, while the uptake remained constant in the presence of hENT inhibition. These results suggest that hENT plays a key role in the process.
Summary of results and concluding remarks
The uptake of ribavirin by the oocytes was not merely the sum of the transport rates through the two types of transporter, hCNT and hENT. It was strongly reduced by the presence of hENT1. This suggests that an interaction mechanism might be involved in the co-transport process between hCNT and hENT. We excluded the possibility that NBMPR directly inhibited the transport activity of hCNT, by measuring the ribavirininduced sodium current. After examining the effect of the expression level of hENT1 on the ribavirin uptake, we concluded that hENT alone played a critical role in the facilitated transport that resulted from hENT inhibition.
This finding is interesting from the point of view not only of drug delivery but also of basic biology. One possible explanation is that ribavirin might be released through hENT, although the concentration of ribavirin is still much lower inside the oocyte than outside according to the estimated volume of the oocyte (0.9 µL). If the ribavirin concentration is not homogeneous in the oocyte due to slow diffusion and/or other reasons, such as trapping by large proteins, this phenomenon might occur. Nonetheless, quantitative analysis is necessary to test the hypothesis and to discover other possibilities. We therefore focused on the kinetics of this co-transport process, and considered a possible kinetic mechanism by means of mathematical modeling of the transport.
Quantitative analysis of ribavirin transport
In this section, we describe a simplified version of the mathematical model [19] . Let us begin with the assumption that the cell is a sphere and that ribavirin simply diffuses inside and outside the cell. We therefore solve the diffusion equations using three-dimensional polar coordinates. Transport across the membrane is mediated only by the transporters, and other forms of transport such as leak are not included. The transporters mediate both inward and outward flows, the dynamics of which obey Michaelis-Menten kinetics.
Although the K m and V M AX generally differ for the two directions of transport, here we assume that they are the same for simplicity. We consider spatial variations only along the radius, assuming that the spatial distribution of the ribavirin concentration always shows spherical symmetry. The model equations are The suffixes in and out express the inward and outward flow, respectively. These fluxes are given by
where C in and C out are the respective ribavirin concentrations directly inside and outside the membrane, n in and n out are the respective sodium concentrations inside and outside the membrane, and V and K are the maximum rate and Michaelis constant, respectively. Exponent 2 in the sodium concentration comes from the fact that hCNT3 transports one molecule of ribavirin and two molecules of sodium ion simultaneously.
Here we simplify the situations based on some physiological considerations. As the amount of ribavirin in the extracellular medium is much larger than that which needs to be transported across the membrane, we can neglect the small change in C out . During the physiological experiment the extracellular medium is stirred well, so the concentration of ribavirin is homogenous in the extracellular space. It can therefore be assumed that C = C out in the extracellular medium. Based on similar considerations for sodium ions, n = n out in the extracellular medium. For n in the intracellular space, we assume that n is constant at n in because homeostasis is maintained quickly enough. Figure 5 shows a schematic illustration of the mathematical modeling.
The details of the numerical calculation are described here. The cell is assumed to be a sphere. The volume of the sphere is 0.9 µl, which is obtained from the experimental measurement (r m = 0.6). The center of the sphere is defined as the origin of the polar coordinate. The extracellular space also follows the coordinate system. r e is the boundary of the extracellular space and r e = 3mm. For the numerical simulation, the space is discretized by a spherical shell with a thickness of 0.005 mm (= ∆). The spherical shell is numbered from the origin outward (shell number j). Then, r m = 120 × ∆r, r e = 600 × ∆r. 
Numerical calculation and results
Parameter search for V M AX and K m in CNT and ENT
The experiment measured the relationship between the extracellular ribavirin concentration and the total uptake when one type of transporter was blocked. From the experiments, we have calculated theV M AX andK m , which is of phenomenological effective process for ribavirin uptake. Actually, however, this effective process consists of not only uptake process but also release process by the transporter and intracellular diffusion process. This means that the V M AX and K m for each process of uptake and release should be determined so as to fit to the experimentally obtainedV M AX andK m for the effective uptake process. This is the important point to be emphasized because one may often confusê V M AX andK m for the effective process with that for the elementary uptake process.
We therefore searched for the appropriate values of V M AX and K m for each process of uptake and release by means of our mathematical model introduced in the previous section, at the fixed value of D in = 12.0µm 2 /sec. Here we assume that V M AX and K m for uptake process are the same as that of release process in order to reduce the degree of freedom in parameter search, but there are still some degree of freedom. Figure 6 shows the error of fitting caused by changing V M AX and K m when one of transporters was blocked. The error was defined as the difference between c in s of the experimentally obtained and the theoretically simulated, which was summed up over a range of c out . We [20] ).
Since nucleoside analogues like ribavirin are highly bioactive and potentially interactive with some protein, it is plausible that diffusion velocity of ribavirin is to be 10 times slower (equivalently 100 times smaller in diffusion constant) in space of protein-rich protoplasm. Figure 8 shows the simulation results. There is a good agreement in all cases for the CNT only, the ENT only, and both. As observed in the experiment, ribavirin uptake is promoted by the inhibition of the ENT. The mathematical model essentially explains the transport dynamics observed in the experiment over a wide range of C out (0.12 µM
Uptake of ribavirin through transporters in the oocyte
How does this increase occur when the ENT is blocked? Figure 9 sheds light on this phenomenon. The ribavirin concentration increased directly inside the membrane when the CNT transported the drug, as the diffusion of ribavirin in the cell was much slower than the time scale of uptake by the CNT. Under these conditions, the ENT transported the drug from inside the cell to outside. Therefore, ribavirin leaked through the ENT.
This explains why the uptake of ribavirin was promoted by the inhibition of the ENT.
This can be inferred from the mathematical model proposed here.
In the model proposed here, we assumed that the V M AX s and K m s for both directions in the CNT were the same. We also made a similar assumption for the ENT. Under these assumptions, we sought the appropriate range of V M AX , K m values. Figure 8 shows an example of the values. However, we predicted that the kinetic parameters would not always be the same, because the transporter changed its molecular structure in different ways between the two directions of transport. As experimental evidence of the kinetic difference between the two directions of transport is limited, model prediction can be generally useful.
Inhibition of uptake by stirring the extracellular medium
In the simulation described above, we assumed that c(r, t) = c out in the extracellular space. However, when the extracellular medium was not stirred and ribavirin diffused through it, the model simulation showed that the uptake of ribavirin was 20% less than that in the case with stirring, as shown in Fig. 10a . Figure 10b indicates the mechanism of inhibition. The ribavirin concentration was low directly outside the membrane because the uptake by the CNT was much faster that the time scale of diffusion in the extracellular medium. The uptake by the CNT then slowed down, as predicted by the model.
Effects of CNT/ENT ratio on the ribavirin uptake
The CNT/ENT ratio is reported to vary in different organs. According to the model analysis described here, ribavirin uptake is promoted more strongly as the ratio of the ENT is reduced relative to the CNT. In the simulation, a 20 -30% difference in the ratio leads to a large difference in the uptake, as shown in Fig. 11 . This implies that organ-selective drug delivery to ENT-poor organs can be achieved by controlling the drug concentration in the circulating blood.
Conclusion
We found that hENT1 reduced the ribavirin uptake via hCNT3 transport through a kinetic interaction of hENT1 and hCNT3 in Xenopus oocytes in which hENT1 and hCNT3 were simultaneously expressed. Quantitative analysis of the kinetics of ribavirin uptake was performed. In the predicted mechanism, the ribavirin pumped inward by hCNT3 was highly concentrated directly inside the membrane due to slow diffusion, and was released outward through hENT1. Based on this mechanism, we proposed that organ-selective drug delivery to ENT-poor organs was feasible by controlling the drug concentration in the circulating blood.
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Figure Captions Dependency of uptake on the ratio of transporters. The ratio in the abscissa axis was given by CNT/(CNT+ENT). The uptake in the ordinate was calculated 10 min after the addition of ribavirin, and expressed the total amount normalized to that of ENT=0. The uptake was reduced as the ratio of the ENT became larger. 
